Page 145 - Simplicity is Key in CRT

50. Mullens W, et al. Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. Am J Cardiol 2011;108(3):409-15.
51. Schmidt S, et al. Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy. Eur Heart J 2014;35(16):1051-60.
52. Bogaard MD, et al. The ECG in cardiac resynchronization therapy: influence of left and right ventricular preactivation and relation to acute response. J Cardiovasc Electrophysiol 2012;23(11):1237-45.
53. van Deursen CJ, et al. The value of the 12-lead ECG for evaluation and optimization of cardiac resynchronization therapy in daily clinical practice. J Electrocardiol 2014;47(2):202-11.
54. Whinnett ZI et al. Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice. Int J Cardiol. 2013;168(3):p 2228-2237
55. Barrold SS et al. Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resyn- chronization. Europace. 2008: Suppl 3: 88-95.
56. Hayes DL, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011;8(9):1469-75.
57. Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32 844 patients. Circ Arrhythm Electrophysiol 2012;5(5):884-8.
58. Chalil S, et al. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;30(10):1201-9.
59. Ypenburg C, et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 2007;99(5):657-60.
60. Verbrugge FH, et al. Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling. J Card Fail 2012;18(11):845-53.
61. Theuns DA, et al. The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comor- bidity burden as predictor of mortality. Europace 2011;13(1):62-9.
62. Shalaby A, et al. Mood disorders and outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electro- physiol 2012;35(3):294-301.
63. Patwala AY, et al. Maximizing patient benefit from cardiac resynchronization therapy with the addition of structured exer- cise training: a randomized controlled study. J Am Coll Cardiol 2009;53(25):2332-9.
64. Piccini JP, et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 2008;118(9):926-33.
65. Altman RK, et al. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J 2012;33(17):2181-8.
66. Singh JP, et al. Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy. Europace 2009;11(12):1647-53.
67. Whellan DJ, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010;55(17):1803-10.
68. Dubner S, et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 2012;14(2):278-93.
69. Crossley G, et al.Trial design of the clinical evaluation of remote notification to reduce time to clinical decision: the Clinical evaluation Of remote NotificatioN to rEduCe Time to clinical decision (CONNECT) study. Am Heart J 2008;156(5):840-6.
70. Varma N, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter- defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010;122(4):325-32.
71. Raatikainen MJ, et al. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace 2008;10(10):1145-51.
72. Saxon LA, et al. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTI- TUDE survival study. Circulation 2010;122(23):2359-67.
145